MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Interpace Biosciences ROA Ratio 2011-2026 | IDXG
Annual ROA Ratio Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.63 | 45.31 | 14.9 | -137.42 | -38.89 | -57.9 | -38.71 | -25.16 | -22.79 | -19.94 | -16.77 | -13.87 | -6.61 | -32.54 | -10.51 | -5.48 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 72.63 | -137.42 | -18.36 |
Quarterly ROA Ratio Interpace Biosciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.9 | 25.68 | 36.9 | 47.92 | 36.56 | 32.25 | 21.41 | 4.83 | -1.0 | -93.91 | -100.7 | -107.65 | -109.86 | -118.7 | -33.77 | -32.26 | -26.41 | -44.23 | -49.04 | -53.28 | -57.9 | -60.77 | -61.57 | -59.64 | -51.88 | -45.0 | -37.01 | -30.85 | -31.16 | -23.69 | -29.16 | -20.68 | -13.92 | -33.07 | -33.54 | -34.29 | -38.64 | -46.62 | -38.52 | -38.53 | -25.86 | -29.7 | -24.01 | -14.34 | -7.53 | -10.63 | -8.06 | -2.69 | -1.3 | -2.6 | -0.06 | 0.87 | -2.21 | -2.38 | -1.87 | -1.8 | -1.45 | -0.18 | -0.79 | -0.49 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.92 | -118.7 | -24.55 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
-4.99 | $ 19.86 | 9.48 % | $ 611 M | USA |
 |
Celcuity
CELC
|
-37.95 | $ 90.8 | 2.07 % | $ 4.25 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 5.95 | 15.09 % | $ 7.91 M | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 21.59 | 5.89 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 134.07 | 5.54 % | $ 16.8 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 23.31 | 4.48 % | $ 1.24 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.41 | $ 153.02 | 6.34 % | $ 12 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
12.79 | $ 168.23 | -1.58 % | $ 26.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 102.2 | 1.95 % | $ 6.9 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 185.37 | 3.06 % | $ 9.19 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 181.46 | 1.04 % | $ 24.4 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
22.84 | $ 456.63 | 1.29 % | $ 13.2 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 11.52 | 13.56 % | $ 1.48 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
-8.68 | $ 225.61 | 6.5 % | $ 30.8 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 19.68 | 3.36 % | $ 440 M | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 4.74 | 7.61 % | $ 439 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 12.3 | 14.1 % | $ 1.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 26.0 | 2.54 % | $ 24.7 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 7.03 | 4.61 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.15 | 1.9 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 260.8 | 0.73 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 75.21 | 3.97 % | $ 4.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 481.71 | 1.64 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.68 | -2.84 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 195.86 | 1.13 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 377.42 | -0.62 % | $ 22.5 B | USA |